• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    1517146 Detection of urea BOEHRINGER MANNHEIM GmbH 22 March 1977 [25 March 1976] 11994/77 Heading G1B [Also in Division C3] A reagent for the detection of urea comprises a stabilized urease which contains, as stabilizing agent, a mixture of glutathione, ethylenediamine tetraacetic acid and citrate, and a system for the detection of ammonia. The preparation of a test film for the detection of urea in blood or serum is described, the said film comprising a polyvinyl chloride film coated with an acid mixture containing the said stabilized urease, bromothymol blue, disodium hydrogen phosphate, polyvinyl acetate dispersion, sodium alginate solution and dioctyl sodium sulphosuccinate.
    公开号:SU743600A3
    申请号:SU772453752
    申请日:1977-02-15
    公开日:1980-06-25
    发明作者:Шнайдер Вальтер；Редер Альберт；Меллеринг Ханс；Гутманн Ингеборг
    申请人:Берингер Маннхайм Гмбх (Фирма)；
    IPC主号:
    专利说明:

    (54) STABILIZED UREA FOR DETERMINATION OF UREA CONTAINING UREASE
    one
    This invention relates to urease-based stabilized formulations which are used in the determination of urea.
    An urease cleaves urea to form carbonic acid and ammonia. A characteristic feature of this enzyme is that, in a wet state, urease is extremely stable during storage, the stability of purified urease drops sharply and is already unsatisfactory with a specific activity of about 25 to 100 mg / mg.
    Normal food consumption with a specific activity of about 100 U / mg is lost in the fridge for half a year in the refrigerator. About 50% of its activity is already in place. Storage at room temperature or in dissolved form leads to even faster loss of activity.
    Attempts to increase the stability of the purified enzyme by changing the pH of the buffer, the ionic strength and the type of buffer (maleate, citrate, ethylenediaminetetraacetic acid, phosphate) or by creating urease-based compounds containing the enzyme
    sulfhydryl groups, as well as cysteine or mercaptoethanol, were unsuccessful.
    A certain slight increase
    Stability 5 was achieved with a composition containing, in addition to urease, double recrystallized plasma albumin from bull 1.
    However, the degree of stability achieved was insufficient for the use of this composition, which was due to the relatively {breakdown of the enzyme and the decrease in its activity.
    15 The purpose of the invention is to increase stability.
    This goal is achieved / according to the invention, with a composition for determining urea, which, in addition to
    20 urease contains a mixture of glutathione, ethylenediaminetetraacetic acid (EDTA) and trisodium citrate in crystalline form, containing 2 molecules of water of crystallization, with
    25 the following ratio of components of urease: glutathione, ethylenediaminetetraacetic acid: citrate 1: (1-3) :( 13): (1-3).
    Proposed stabilized
    30 The formulation contains urease, preferably pretreated with Sephadex. By treatment with Sephadex, the stability of the preparation is doubled. Impurities that cannot be stabilized are removed as a result of this treatment, so that the urease preparation based on the stabilizing composition is characterized by particularly high stability after the addition of a mixture of stabilizers. Treatment with Sephadex can be performed both as a result of a single injection, Sephadex into the enzyme solution, and on a column. Preferably, cross-linked Sephadex with molecular sieve properties is used, since at the same time, desalting of ureae along with enrichment and removal of interfering impurities attain simultaneously. The differences in the proposed composition are the presence in it, in addition to the enzyme glutathione, ethylene diamine tetraacetic acid. (EDTA) and trisodium citrate crystalline hydrate, as well as the ratio of components is 1: (1-3): (1-3): (1-3). An unexpected is the stabilizing effect of the mixture of the three substances mentioned (glutathione, EDTA, citrate), although it is known that the individual components of this mixture do not have a stabilizing effect. The proposed stabilized composition, containing urease obtained after lyophilization of the mixture after 12 weeks storage at FFA, is almost completely stable and exhibits 100% of the activity compared to the initial one. After lyophilization, the enzyme itself loses activity from 30 to 80%. The stabilized, according to the invention, composition containing urease is used for the determination of urea. It is so stable that it is suitable for impregnating paper, captive and the like or for the production of reactive layers on such media. If such a carrier or a similar layer additionally contains a pH indicator, then urea can be determined by a single change in the spray pattern. Example. 30 mg of a normal sale urease with a specific activity of about 100 and / mg is dissolved in 1 ml of water, passed through 5 ml of gel with a G-50 gel pre-equilibrated with citrate buffer pH 7.0, with 0.5% 2 -mercaptoethanol, and immediately thereafter lyophilized. The lyophilized preparation is then subjected to a stability test as a result of storage at. In the second column, the experiment described above is repeated, in which glutathione, citrate and EDTA are added to the enzyme treated with the crosslinked Sephadex G-50 in a weight ratio of 1: 1: 1: 1. The lyophilization and storage are then repeated as described in the first experiment. In the case of the first experiment without the addition of a stabilizing agent, the yield of activity after freeze-drying is 20%. After 6 weeks storage at 35 ° C, the residual activity measured is less than 1%. In the second experiment with a stabilizing agent according to the invention, the activity after lyophilization is 100%. After 3 months, the activity is also 100%. Example 2. 150 mg of a typical commercial urease with a specific activity of about 100 and / mg is dissolved in 100 ml of water, mixed with 150 mg of glutathione, 150 mg of citrate and 150 mg of EDTA in a weight ratio of 1: 1: 1: 1 and without treatment with Sephadex lyophilized. Baseline activity is determined in the lyophilisate. It is 100%. The lyophilisate is then stored at. After 6 weeks of storage, the activity is still 95% of the initial value. Example 3. A urease with a specific activity of about 1500 and / mg is obtained from the usual commercial urease as a result of repeated crystallization of IE with acetone-citrate buffer and treatment with Sephadex. The resulting drug. (10 mg) is mixed with 30 mg of glutathione, 30 mg of citrate and 30 mg of EDTA in a weight ratio of 1: 3: 3: 3. Stability at storage at corresponds to urease of 100 and / mg. Example 4. Test film for urea (in blood or serum). Components: powdered polyvinyl acetate propionate 45.0 g, 1.93% solution of sodium alginate in water 10.0 g dioxyl sodium sulfosuccinate 0.5 g, stabilized ureaaa (1: 1: 1: 1) plus dissolved in water (in 10 ml) brothymol b, dissolved in 5 ml of methanol, plus 5 ml of water (10,000 U), 0.25 g of disodium hydrogen phosphate 0.9 g. The ingredients are mixed well by adding 1N. The HC1 solution is adjusted to pH 6.0. The mass is applied to the polyvinyl chloride film and dried for 60 minutes with urea-containing blood or serum being dropped in and after erasing it after 90 seconds the following color appears: 20 mg% urea yellow, 60 mg urea-yellow-green, 100 mg% urea - green, 200 mg% urea - dark green.
    After 3 days storage, this test film reacts almost unchanged.
    A test film of the same composition and manufacture, but which contains, instead of a stabilized according to the invention, urease, an unstabilized urease of the same activity, initially shows almost the same color during the reaction, but after storage for 3 days with no longer suitable.
    权利要求:
    Claims (2)
    [1]
    1. A stabilized urea formulation containing
    urease, characterized in that, in order to increase stability, it additionally contains a mixture of glutathione, ethylenediaminetetraacetic acid and trisodium citrate in crystalline form, containing 2 molecules of crystallization water, in the following ratio of urease components: glutathione, ethylenediamine tetraacetic acid: citrate 1: ) :( 1-3) :( 1-3).
    [2]
    2. Method POP.1, characterized in that uraza is pretreated with Sephadex.
    Sources of information taken into account in the examination
    1, Lynn K.R. Preperties
    5 and Purifications of JreaseV, Biochimica et Biophysica Acta, 1967, 146, p.205-218 (prototype).
    类似技术:
    公开号 | 公开日 | 专利标题
    SU743600A3|1980-06-25|Urease-containing stabilized composition for urea determining
    Shipolini et al.1971|Phospholipase A from bee venom
    EP0100982B2|1991-05-29|Novel purified plasminogen activator, process for its production and thrombolytic composition containing it
    Krietsch et al.1970|3‐Phosphoglycerate kinase from rabbit sceletal muscle and yeast
    Schwartz et al.1973|Human factor XIII from plasma and platelets: molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin
    US4160025A|1979-07-03|Method of producing a blood-coagulation-promoting preparation from human blood plasma
    Mackworth1948|The inhibition of thiol enzymes by lachrymators
    Latallo et al.1964|Inhibition of thrombin and of fibrin polymerization, two activities derived from plasmin-digested fibrinogen
    Puszkin et al.1975|Adenosine diphosphate effect on contractility of human muscle actomyosin: inhibition by ethanol and acetaldehyde
    Fincham1962|Genetically determined multiple forms of glutamic dehydrogenase in Neurospora crassa
    Sherry et al.1957|Studies on the fibrinolytic enzyme of human plasma
    Helmkamp et al.1969|β-Hydroxydecanoyl thioester dehydrase: studies on molecular structure and active site
    Balls et al.1955|Acetyl-chymotrypsin
    Abel et al.1995|Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human platelets
    CA1094449A|1981-01-27|Plasminogen activator complex
    D'Alessio et al.1971|Glyceraldehyde phosphate dehydrogenase of Escherichia coli: structural and catalytic properties
    Janoff et al.1971|Further studies on elastase-like esterases in human leukocyte granules
    EP0426100B1|1994-12-14|Stabilized enzyme compositions
    Fernando et al.1969|Fructose diphosphatase from rabbit muscle: II. Amino acid composition and activation by sulfhydryl reagents
    Hamada et al.1975|Purification, properties, and subunit composition of pig heart lipoate acetyltransferase
    Kortt et al.1974|Ficins |. Purification and characterization of the enzymic components of the latex of Ficus glabrata
    CA1053661A|1979-05-01|Protease-free proteins, and methods of manufacturing and using the same
    CA1205012A|1986-05-27|Method for the production of therapeuticallyadministrable plasma derivatives filled in finalcontainers
    Ciardi et al.1973|Multiple forms of glutamine synthetase. Hybrid formation by association of adenylylated and unadenylylated subunits
    Ratner1957|[93] Preparation and determination of argininosuccinic acid
    同族专利:
    公开号 | 公开日
    SE7703206L|1977-09-26|
    BE852791A|1977-09-23|
    DE2612726A1|1977-10-06|
    FR2345460B1|1982-12-17|
    BR7701770A|1978-01-17|
    FI56536B|1979-10-31|
    FI56536C|1980-02-11|
    NL188169C|1992-04-16|
    JPS6027516B2|1985-06-29|
    NL188169B|1991-11-18|
    FI770294A|1977-09-26|
    CA1086615A|1980-09-30|
    JPS52117488A|1977-10-01|
    DE2612726C3|1979-03-15|
    IT1076016B|1985-04-22|
    DE2612726B2|1978-07-06|
    SE428475B|1983-07-04|
    AU509593B2|1980-05-15|
    HU179124B|1982-08-28|
    NL7700686A|1977-09-27|
    GB1517146A|1978-07-12|
    CH629535A5|1982-04-30|
    ATA5477A|1978-09-15|
    FR2345460A1|1977-10-21|
    US4188465A|1980-02-12|
    AR210632A1|1977-08-31|
    AU2356277A|1978-09-28|
    DD129692A5|1978-02-01|
    AT349651B|1979-04-25|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    RU2563834C2|2010-08-20|2015-09-20|Цитонет Гмбх Унд Ко. Кг|Method of extracting urea with removal of unwanted co2|FR1321659A|1961-03-20|1963-03-22|Albert L Chaney Chemical Lab|Method for determining nitrogen in biological fluids|
    USRE26125E|1962-05-08|1966-12-13|Reagents and analysis of nitrogen |
    US3527674A|1966-06-30|1970-09-08|Calbiochem|Reagent material and method for urea assay|
    US3542649A|1967-04-07|1970-11-24|Hoffmann La Roche|Color developing composition consisting of an enzyme,a salicylate and a hypochlorite donor|
    DE1758581C3|1968-06-29|1974-01-10|Demag Ag, 4100 Duisburg|Support device for a metallurgical vessel, in particular for a steelworks converter|
    ZA733611B|1972-10-11|1974-04-24|Merck Patent Gmbh|Indicator for the determination of urea|
    DE2329174C2|1973-06-07|1975-07-24|Boehringer Mannheim Gmbh, 6800 Mannheim|Method for the quantitative determination of blood ammonia|US4378430A|1979-09-11|1983-03-29|Modrovich Ivan Endre|Method of forming stabilized urease solutions|
    US4282316A|1979-09-11|1981-08-04|Modrovich Ivan Endre|Stabilized enzymic solutions for determining urea|
    US4465770A|1979-09-11|1984-08-14|Modrovich Ivan Endre|Stabilized enzymic solutions for determining urea|
    US4350659A|1981-07-30|1982-09-21|Corning Glass Works|Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives|
    JPS62502653A|1985-02-11|1987-10-15|
    US7422903B2|2002-12-11|2008-09-09|Instrumentation Laboratory Company|Multi-analyte reference solutions|
    US20040154933A1|2003-02-11|2004-08-12|Instrumentation Laboratory Company|Polymeric membranes for use in electrochemical sensors|
    US20040256227A1|2003-02-11|2004-12-23|Jungwon Shin|Electrochemical urea sensors and methods of making the same|
    US20050176650A1|2004-02-09|2005-08-11|Xanodyne Pharmacal, Inc.|Stable parenteral formulation of levomepromazine and a method for stabilizing said formulation|
    RU2464015C2|2006-12-15|2012-10-20|Лайфбонд Лтд.|Gelatin-transglutaminase hemostatic bandages and isolating agents|
    US8367388B2|2008-06-18|2013-02-05|Lifebond Ltd.|Cross-linked compositions|
    EP2543394A1|2008-06-18|2013-01-09|Lifebond Ltd|A method for enzymatic cross-linking of a protein|
    CA2728186A1|2008-06-18|2009-12-23|Lifebond Ltd|Methods and devices for use with sealants|
    DE102009057050A1|2009-12-04|2011-06-09|Torsten Beel|Urine-indicator-unit for use in toilets for detecting fresh and dried urine, has indicator for colored detection of fresh and dried urine and its contents|
    ES2551388T3|2009-12-22|2015-11-18|Lifebond Ltd|Modification of enzymatic crosslinking agents to control the properties of crosslinked matrices|
    CN103118713B|2010-08-05|2016-06-01|生命连结有限公司|Dry composition wound dressing and binding agent|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE2612726A|DE2612726C3|1976-03-25|1976-03-25|Stabilized urease|
    [返回顶部]